Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma
- 15 November 1999
- Vol. 86 (10) , 1976-1984
- https://doi.org/10.1002/(sici)1097-0142(19991115)86:10<1976::aid-cncr14>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factorCancer, 1998
- Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.Journal of Clinical Oncology, 1998
- Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.Journal of Clinical Oncology, 1998
- Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosisInternational Journal of Cancer, 1997
- Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: A prospective studyJournal of Surgical Oncology, 1994
- Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the LungNew England Journal of Medicine, 1990
- DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinomaCancer, 1989
- Nuclear DNA Content by Cytofluorometry of Stage I Adenocarcinoma of the Lung in Relation to Postoperative RecurrenceChest, 1989